Mef2d potentiates type-2 immune responses and allergic lung inflammation

成果类型:
Article
署名作者:
Szeto, Aydan C. H.; Clark, Paula A.; Ferreira, Ana C. F.; Heycock, Morgan; Griffiths, Emma L.; Jou, Eric; Mannion, Jonathan; Luan, Shi-Lu; Storrar, Sophie; Knolle, Martin D.; Kozik, Patrycja; Jolin, Helen E.; Fallon, Padraic G.; Mckenzie, Andrew N. J.
署名单位:
MRC Laboratory Molecular Biology; University of Cambridge; Trinity College Dublin; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of Cambridge
刊物名称:
SCIENCE
ISSN/ISSBN:
0036-14025
DOI:
10.1126/science.adl0370
发表日期:
2024-06-28
关键词:
innate lymphoid-cells transcription factor gata3 t-cells specifies lineage gene-expression helper-cells protein differentiation promotes cloning
摘要:
Innate lymphoid cells (ILCs) and adaptive T lymphocytes promote tissue homeostasis and protective immune responses. Their production depends on the transcription factor GATA3, which is further elevated specifically in ILC2s and T helper 2 cells to drive type-2 immunity during tissue repair, allergic disorders, and anti-helminth immunity. The control of this crucial up-regulation is poorly understood. Using CRISPR screens in ILCs we identified previously unappreciated myocyte-specific enhancer factor 2d (Mef2d)-mediated regulation of GATA3-dependent type-2 lymphocyte differentiation. Mef2d-deletion from ILC2s and/or T cells specifically protected against an allergen lung challenge. Mef2d repressed Regnase-1 endonuclease expression to enhance IL-33 receptor production and IL-33 signaling and acted downstream of calcium-mediated signaling to translocate NFAT1 to the nucleus to promote type-2 cytokine-mediated immunity.